Skip to main content
. 2023 Jan 9;43:3. doi: 10.1186/s41232-022-00253-3

Fig. 2.

Fig. 2

Inhibition of NAK pathway by baricitinib. Baricitinib includes inhibition of viral receptor-mediated endocytosis, which involves the NF-κB activating kinase (NAK) family